International Pharmaceutical Manufacturers Group

What International Pharmaceutical Manufacturers Group does

International Pharmaceutical Manufacturers Group (IPMG) is an Indonesia-based industry association that serves as the unified representative body for 25+ research-based multinational pharmaceutical companies operating in the country, including named members such as Actavis and Abbott. Headquartered under the legal entity ipmg-online Inc., IPMG functions as an advocacy and policy intermediary rather than a commercial enterprise: it engages Indonesian government agencies, regulators, and healthcare stakeholders on issues including patient access to innovative medicines, ethical pharmaceutical marketing, counterfeit drug protection, halal compliance, intellectual property rights, and national healthcare program support.

The association's core deliverables are advocacy programs and codified standards — most notably its Code of Ethics (with published revisions in 2019, 2021, and 2025) and its alignment with the IFPMA Code of Practice. IPMG also publishes science and healthcare resources focused on Cancer, Diabetes, Special Treatment Therapy, and Vaccines, and produces an annual report (IPMG AR 2025) and a formal Manifesto. Its public-facing infrastructure is a bilingual (English/Indonesian) website at ipmg-online.com, supported by a small secretariat.

IPMG's business model is membership-funded: the 25+ multinational pharmaceutical companies pay dues that support a lean secretariat of approximately 5 employees executing advocacy, member communications, and publication work. The organization is governed by a Board of Management, a Board of Supervisors, and a Secretariat, reflecting a member-governed association structure rather than a commercial operator. No pricing, product sales, or commercial distribution model exists; revenue, ARR, and growth metrics are not publicly disclosed.

Name

International Pharmaceutical Manufacturers Group

Legal name

ipmg-online Inc.

Website

https://ipmg-online.com

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

International Pharmaceutical Manufacturers Group (IPMG) is an Indonesia-based industry association representing 25+ multinational pharmaceutical companies. It advocates for ethical marketing, patient access, IP rights, and healthcare policy through a small secretariat, governed by member companies.

Ownership category

akta.pro rank

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Marketing channels1 record

Core offering

IPMG is an industry association representing 25+ research-based multinational pharmaceutical companies operating in Indonesia. Its core activity is advocacy and policy engagement on behalf of members, covering ethical pharmaceutical marketing standards (Code of Ethics), counterfeit drug protection, halal compliance, intellectual property rights protection, and support for Indonesia's national healthcare system. It does not manufacture, sell, or distribute pharmaceutical products or commercial software offerings.

Product overview

International Pharmaceutical Manufacturers Group (IPMG) is a research-based multinational pharmaceutical organization in Indonesia operating as an industry association rather than a product company. IPMG serves as a unifying body for 25+ multinational pharmaceutical member companies, offering advocacy programs focused on ethical marketing (Code of Ethics), patient safety (Counterfeit Drug Protection), regulatory compliance (Halal, Patent Protection), healthcare system support (National Healthcare Program), and science information resources (Cancer, Diabetes, Vaccines, Special Treatment Therapy). The organization provides resource document libraries including Code of Ethics revisions and annual reports, functioning as a government partner to improve healthcare systems through constructive dialogue and policy advocacy.

Differentiator

Problem solved

Functional benefit

Products and services

• Code of Ethics Program Self-regulatory program setting ethical marketing and compliance standards for IPMG's multinational pharmaceutical member companies operating in Indonesia, with documented revisions in 2019, 2021, and 2025.
• Healthcare Science Information Resource Published science and healthcare innovation information resource covering Cancer, Diabetes, Special Treatment Therapy, and Vaccines focus areas for member companies, healthcare professionals, and the public.
• Counterfeit Drug Protection Initiative Industry initiative protecting patients from counterfeit pharmaceutical products in Indonesia through industry awareness and support for enforcement actions.
• Halal Compliance Advisory Advisory service providing guidance and support for IPMG member companies on halal compliance requirements applicable to pharmaceutical products in Indonesia.
• Intellectual Property Rights Protection Advocacy Policy advocacy program supporting the protection of intellectual property rights and patents for pharmaceutical research, development, and innovation in Indonesia.
• National Healthcare Program Support Advocacy and collaboration program supporting Indonesian national healthcare system programs and policies on behalf of multinational pharmaceutical members.
• Resource Documents Library Online library providing access to IPMG Code of Ethics documents across revisions (2019, 2021, 2025) and the IFPMA Code of Practice documentation for member companies and stakeholders.
• Annual Reports Published annual reports including the IPMG Annual Report 2025 and Laporan Tahunan (Indonesian-language annual report), providing organizational updates, activities, and transparency information for members and stakeholders.

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• IFPMA (International Federation of Pharmaceutical Manufacturers & Associations)coreStrategic or Co-development PartnerIPMG is associated with IFPMA and follows the IFPMA Code of Practice. The IFPMA Code of Practice document is available as a resource on IPMG's website, indicating alignment with international pharmaceutical industry standards for ethical marketing practices.
• Member Companies (25+ multinational pharmaceutical companies)coreOthersIPMG represents 25+ research-based multinational pharmaceutical member companies in Indonesia including Actavis, Abbott, and others. Member companies include image logos displayed on the IPMG website representing various pharmaceutical organizations operating in Indonesia.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• International Generic and Biosimilar Medicines Association (IGBA): Global association representing generics and biosimilars manufacturers. Operates the same advocacy-for-pharma-members model as IPMG but on the generics side; a useful counterpart for understanding industry-association dynamics in the same regulatory environment.
• FIFARMA (Federación Latinoamericana de la Industria Farmacéutica): Latin American pharma industry federation representing research-based manufacturers across multiple markets. Same industry-association advocacy model applied across emerging markets, comparable to IPMG's Indonesian footprint.
• Japan Pharmaceutical Manufacturers Association (JPMA): Japanese pharma industry association with similar mandate covering code of ethics, IP advocacy, and government dialogue. Comparable structure and member base to IPMG.
• European Federation of Pharmaceutical Industries and Associations (EFPIA): European pharma industry federation representing research-based companies. Operates the same advocacy-plus-self-regulation model as IPMG, focused on a regional rather than single national market.
• Pharmaceutical Security Institute (PSI): International non-profit addressing pharmaceutical crime and counterfeit drugs. Directly comparable to IPMG's Counterfeit Drug Protection program and shared anti-counterfeit advocacy mission.
• Pharmaceutical Research and Manufacturers of America (PhRMA): U.S. national trade association for research-based pharmaceutical companies. Mirrors IPMG's role of representing multinational pharma on policy, IP, and ethical marketing at the country level.
• Medicines Australia: Australian peak body for the research-based pharmaceutical industry. Same advocacy-plus-code-of-conduct model and similar multinational member profile as IPMG.
• International Federation of Pharmaceutical Manufacturers & Associations (IFPMA): Global federation of pharma industry associations and companies. IPMG is explicitly associated with IFPMA and adopts its Code of Practice, making IFPMA the closest comparable in mission and operating model.
• Association of the British Pharmaceutical Industry (ABPI): UK pharma trade association enforcing a Code of Practice for member companies. Highly comparable in self-regulatory and government-partner functions to IPMG.
• Korea Pharmaceutical Manufacturers Association (KPMA): Korean pharma manufacturers association engaging on ethics, IP, and government policy. Comparable size, structure, and emerging-market regulatory focus to IPMG.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/international-pharmaceutical-manufacturers-group

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about International Pharmaceutical Manufacturers Group